Remove Doctors Remove Drug Development Remove Pharmaceuticals Remove Pharmacy
article thumbnail

Beyond the Big Three PBMs: Examining a Potential Trend

Perficient: Drug Development

Prescription drugs reach patients through a complex web of entities. Among these, pharmacy benefit managers (PBMs) play a crucial role, handling reimbursements and negotiations with drug manufacturers and pharmacies. This ongoing struggle contributes to the broader atmosphere of tension within the pharmaceutical sector.

article thumbnail

Top 10 Life Science Resources

Alta Sciences

Podcast : FDA Guidance for Industry Psychedelic Drugs Extensively studied for potential therapeutic efficacy, psychedelic drug development comes with its own set of clinical development requirements. TOP MANUFACTURING AND ANALYTICAL RESOURCES The Altascientist : Issue No. Listen here. The Altascientist : Issue No.

Science 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis appoints Rob Kowalski as Chief People & Organization Officer

The Pharma Data

Global Head Regulatory Affairs and US Head of Drug Development as Chief People & Organization Officer. Dr. Kowalski is a senior drug development and regulatory executive with over 25 years of industry experience. Novartis announced today the appointment of Rob Kowalski, Pharm.D., He will report to Vas Narasimhan, M.D.,

article thumbnail

#WhyIScience Q&A: A biochemist uses mass spectrometry to find proteins involved in cancer

Broad Institute

When Moe Haines first moved from Beirut, Lebanon to the United States for college, his goal was to earn a degree in pharmacy. After graduating from college, Haines moved closer to his passion for proteomics, working as an analytical development research scientist for a pharmaceutical company in Albany, NY before relocating to Massachusetts.

Science 106
article thumbnail

Beyond blood tests: The evolution of digital biomarkers in clinical research

Drug Discovery World

In certain cases, to pinpoint the specific type of ILD and its severity, doctors might recommend a lung biopsy. About the author Deepika Khedekar is a Clinical Trial Lead at IQVIA, where she spearheads clinical trial monitoring programmes for major pharmaceutical companies. Acta Pharm Sin B 2022;12(7):3049-3062.

article thumbnail

How large language models can elevate clinical research

Drug Discovery World

billion 1 is the estimated cost of bringing a new drug from the drawing board to pharmacy shelves today. By doing so, LLMs can uncover valuable insights that inform decision-making processes, enhance the accuracy of clinical research outcomes, and streamline the development of therapeutic interventions.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Harini joined Serna Bio in early 2021 and has been an integral part of the multidisciplinary teamworking on target ID platform development to drug discovery. I pursued a degree in Pharmacy from the University of Murcia to become a qualified Pharmacist, followed by an MSc in Cancer Pharmacology at London Metropolitan University.